Ambalal Sarabhai Enterprises Ltd. (INDIA)
Hydroxyurea-hydrosar
“Hydroxyurea” is the Drug / Molecule content in “Hydrosar”. Hydrosar is an anti-cancer chemotherapy drug. Hydrosar is classified as an "antimetabolite."
Indication
Hydrosar is used for the treatment of Refractory ovarian cancer, Polycythemia vera, HypereosinophilicSyndrome. It is also used to reduce the rate of painful attacks in sickle-cell disease and has antiretroviral properties in diseases such as AIDS.
Note
Precaution
- Hydrosar is prescription drug and should be used under proper medical guidance and advice.
- Contraindicated in pregnancy and pregnancy.
Updated On Oct 26, 2019 by Admin
Strength
500 mg
Packing
1 X 10 Capsules (Strip)
Storage
Store at room temperature (25°C).
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Imatinib-veenat
CELGENE
Revlimid-lenalid
NOVARTIS
Afinitor-evertor
Bayer
Nexavar-soranib
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)